{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T14:40:36Z","timestamp":1774276836952,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejogrb.2024.08.001","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T15:48:24Z","timestamp":1722700104000},"page":"77-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Examining the predictive value of fetal fraction on hypertensive disorders of pregnancy"],"prefix":"10.1016","volume":"301","author":[{"given":"Elizabeth","family":"Cochrane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahera","family":"Doctor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Tavella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethany","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Stratis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Stoffels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea","family":"DeBolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejogrb.2024.08.001_b0005","doi-asserted-by":"crossref","first-page":"259.e1","DOI":"10.1016\/j.ajog.2022.01.019","article-title":"Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation","volume":"227","author":"Dar","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.08.001_b0010","article-title":"Fetal fraction of cell-free DNA in noninvasive prenatal testing and adverse pregnancy outcomes: a nationwide retrospective cohort study of 56,110 pregnant women","author":"Becking","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.08.001_b0015","article-title":"Screening for fetal chromosomal abnormalities: ACOG practice bulletin, number 226","volume":"136","author":"American College of Obstetricians and Gynecologists (ACOG)","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.08.001_b0020","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/uog.20290","article-title":"First-trimester screening for trisomies by cffDNA testing of maternal blood in singleton and twin pregnancies: Factors affecting test failure","volume":"53","author":"Galeva","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.08.001_b0025","doi-asserted-by":"crossref","first-page":"300.e1","DOI":"10.1016\/j.ajog.2023.03.026","article-title":"Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening results","volume":"229","author":"Norton","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.08.001_b0030","first-page":"10","article-title":"Factors affecting the fetal fraction in noninvasive prenatal screening: A review","author":"Deng","year":"2022","journal-title":"Front Pediatr"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.08.001_b0035","doi-asserted-by":"crossref","first-page":"417.e1","DOI":"10.1016\/j.ajog.2021.04.212","article-title":"Obesity and no call results: Optimal timing of cell-free DNA testing and redraw","volume":"225","author":"Hopkins","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.08.001_b0040","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","author":"Acog","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.08.001_b0045","first-page":"283","article-title":"Racial\/ethnic differences in pregnancy-related hypertensive disease in nulliparous women","volume":"24","author":"Ghosh","year":"2014","journal-title":"Ethn Dis"},{"issue":"21","key":"10.1016\/j.ejogrb.2024.08.001_b0050","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1080\/14767058.2019.1581522","article-title":"Preeclampsia outcomes at delivery and race","volume":"33","author":"Gyamfi-Bannerman","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ejogrb.2024.08.001_b0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2105\/AJPH.2005.068577","article-title":"Racial disparity in hypertensive disorders of pregnancy in New York State: A 10-year longitudinal population-based study","volume":"97","author":"Tanaka","year":"2007","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.08.001_b0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0039-1700860","article-title":"Low fetal fraction and birth weight in women with negative first-trimester cell-free DNA screening","volume":"37","author":"Clapp","year":"2020","journal-title":"Am J Perinatol"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.08.001_b0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0039-1694005","article-title":"High fetal fraction on first trimester cell-free DNA aneuploidy screening and adverse pregnancy outcomes","volume":"37","author":"Shook","year":"2020","journal-title":"Am J Perinatol"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.08.001_b0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap): A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ejogrb.2024.08.001_b0075","unstructured":"SAS. Version 9.4. Cary, NC: SAS Institute Inc.; 2013."},{"issue":"10","key":"10.1016\/j.ejogrb.2024.08.001_b0080","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/pd.6028","article-title":"Association between low fetal fraction in cell-free DNA testing and adverse pregnancy outcome: A systematic review","volume":"41","author":"Scheffer","year":"2021","journal-title":"Prenat Diagn"},{"issue":"10","key":"10.1016\/j.ejogrb.2024.08.001_b0085","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/pd.6221","article-title":"Lower fetal fraction in clinical cell-free DNA screening results is associated with increased risk of hypertensive disorders of pregnancy","volume":"42","author":"Madala","year":"2022","journal-title":"Prenat Diagn"},{"issue":"8","key":"10.1016\/j.ejogrb.2024.08.001_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2023.101012","article-title":"Low first-trimester fetal fraction is associated with chronic inflammation in the placenta","volume":"5","author":"Suresh","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.08.001_b0095","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-0038-1667374","article-title":"Association of fetal fraction of cell-free DNA and hypertensive disorders of pregnancy","volume":"36","author":"Bender","year":"2019","journal-title":"Am J Perinatol"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.08.001_b0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.placenta.2012.11.001","article-title":"Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications","volume":"34","author":"Kim","year":"2013","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.08.001_b0105","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ajog.2003.12.019","article-title":"Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia","volume":"190","author":"Levine","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.08.001_b0110","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2019.04.002","article-title":"Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy","volume":"16","author":"Gerson","year":"2019","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.08.001_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2021.100463","article-title":"Association between low fetal fraction and hypertensive disorders of pregnancy in in vitro fertilization-conceived pregnancies","volume":"3","author":"Cagino","year":"2021","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"7","key":"10.1016\/j.ejogrb.2024.08.001_b0120","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10815-022-02488-y","article-title":"The low fetal fraction at the first trimester is associated with adverse pregnancy outcomes in IVF singleton pregnancies with single embryo transfer from frozen cycles","volume":"39","author":"Zou","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.ejogrb.2024.08.001_b0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejogrb.2018.03.048","article-title":"Fetal cell-free DNA fraction in maternal plasma for the prediction of hypertensive disorders of pregnancy","volume":"224","author":"Suzumori","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.08.001_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100671","article-title":"Association of fetal fraction with hypertensive disorders of pregnancy incidence and disease severity","volume":"4","author":"Shree","year":"2022","journal-title":"Am J Obstet Gynecol MFM"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524004287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524004287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T06:54:29Z","timestamp":1728370469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211524004287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":26,"alternative-id":["S0301211524004287"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.08.001","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining the predictive value of fetal fraction on hypertensive disorders of pregnancy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}